Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.151\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCCCn1c(N)c(N(CC(C)C)C(=O)C2CCN(c3ncnc4sc(C)c(C)c34)CC2)c(=O)[nH]c1=O
b: O=C(CCCNS(=O)(=O)c1cccc2nsnc12)NC1CCCCC1
Answer: b. O=C(CCCNS(=O)(=O)c1cccc2nsnc12)NC1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCCNS(=O)(=O)c1cccc2nsnc12)NC1CCCCC1
O=C(CCCNS(=O)(=O)c1cccc2nsnc12)NC1CCCCC1
4-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-cyclohexylbutanamide